Application of targeted proteomics and biological parts assembly in E. coli to optimize the biosynthesis of an anti-malarial drug precursor, amorpha-4,11-diene

Han Min Woo; Gregory Murray; Tanveer S. Batth; Nilu Prasad; Paul D. Adams; Jay D Keasling; Christopher J. Petzold; Taek Soon Lee

doi:10.1016/j.ces.2013.04.033

Back

Application of targeted proteomics and biological parts assembly in E. coli to optimize the biosynthesis of an anti-malarial drug precursor, amorpha-4,11-diene

Article 2013 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene

Jennifer R. Anthony, Larry C. Anthony, Farnaz Nowroozi, Gina Kwon, Jack D. Newman, Jay D Keasling

Article2009

High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli

Hiroko Tsuruta, Christopher J. Paddon, Diana G. Eng, Jacob R. Lenihan, Tizita Horning, Larry C. Anthony, Rika Regentin, Jay D Keasling, Neil S. Renninger, Jack D. Newman

Article2012

Application of targeted proteomics to metabolically engineered <i><scp>E</scp>scherichia coli</i>

Pragya Singh, Tanveer S. Batth, Darmawi Juminaga, Robert H. Dahl, Jay D Keasling, Paul D. Adams, Christopher J. Petzold

Article2006

High‐level production of amorpha‐4,11‐diene in a two‐phase partitioning bioreactor of metabolically engineered <i>Escherichia coli</i>

Jack D. Newman, Jessica Marshall, Michelle C. Y. Chang, Farnaz Nowroozi, Eric M. Paradise, Douglas J. Pitera, Karyn L. Newman, Jay D Keasling

Article2016

Photosynthetic conversion of CO2 to farnesyl diphosphate-derived phytochemicals (amorpha-4,11-diene and squalene) by engineered cyanobacteria

Sun Young Choi, Hyun Jeong Lee, Jae‐Yeon Choi, Jiye Kim, Sang Jun Sim, Youngsoon Um, Yunje Kim, Taek Soon Lee, Jay D Keasling, Han Min Woo